PL1729746T3 - Środki do przezskórnego podawania nikotyny - Google Patents

Środki do przezskórnego podawania nikotyny

Info

Publication number
PL1729746T3
PL1729746T3 PL05708757T PL05708757T PL1729746T3 PL 1729746 T3 PL1729746 T3 PL 1729746T3 PL 05708757 T PL05708757 T PL 05708757T PL 05708757 T PL05708757 T PL 05708757T PL 1729746 T3 PL1729746 T3 PL 1729746T3
Authority
PL
Poland
Prior art keywords
nicotine
transdermal administration
devices
well
administration
Prior art date
Application number
PL05708757T
Other languages
English (en)
Inventor
Eva Anette Katarina Lindell
Per Fredrik Nicklasson
Maarit Kristina Thyresson
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0400685A external-priority patent/SE0400685D0/xx
Application filed by Mcneil Ab filed Critical Mcneil Ab
Publication of PL1729746T3 publication Critical patent/PL1729746T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL05708757T 2004-03-19 2005-03-10 Środki do przezskórnego podawania nikotyny PL1729746T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0400685A SE0400685D0 (sv) 2004-03-19 2004-03-19 Means for transdermal administration of nicotine
US55887404P 2004-04-02 2004-04-02
PCT/IB2005/000673 WO2005089728A2 (en) 2004-03-19 2005-03-10 Means for transdermal administration of nicotine
EP05708757A EP1729746B1 (en) 2004-03-19 2005-03-10 Means for transdermal administration of nicotine

Publications (1)

Publication Number Publication Date
PL1729746T3 true PL1729746T3 (pl) 2010-03-31

Family

ID=34961693

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05708757T PL1729746T3 (pl) 2004-03-19 2005-03-10 Środki do przezskórnego podawania nikotyny

Country Status (14)

Country Link
US (1) US20090130189A1 (pl)
EP (1) EP1729746B1 (pl)
AT (1) ATE448777T1 (pl)
AU (1) AU2005224182B2 (pl)
BR (1) BRPI0508894A (pl)
CA (1) CA2559640C (pl)
DE (1) DE602005017753D1 (pl)
DK (1) DK1729746T3 (pl)
ES (1) ES2334681T3 (pl)
IL (1) IL177483A0 (pl)
NZ (1) NZ549939A (pl)
PL (1) PL1729746T3 (pl)
RU (1) RU2334507C2 (pl)
WO (1) WO2005089728A2 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080287507A1 (en) * 2007-05-16 2008-11-20 John Hedenstrom Nicotine containing toiletry waters
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
US20110213335A1 (en) * 2008-11-18 2011-09-01 Burton Scott A Hollow microneedle array and method
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
WO2011044175A2 (en) 2009-10-06 2011-04-14 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US9017310B2 (en) 2009-10-08 2015-04-28 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including microneedles
US8882748B2 (en) * 2009-10-08 2014-11-11 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including chemical permeation enhancers
US9014799B2 (en) 2009-10-08 2015-04-21 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including electrically-actuated permeation enhancement
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
AU2011200392B2 (en) * 2011-01-31 2015-05-28 Palo Alto Research Center Incorporated Transmucosal drug delivery device
AU2012214085B2 (en) 2011-02-11 2015-07-09 Nicoventures Trading Limited Inhaler component
WO2012129576A2 (en) 2011-03-24 2012-09-27 Incube Labs, Llc System and method for biphasic transdermal iontophreotic delivery of therapeutic agents
WO2012154704A2 (en) 2011-05-06 2012-11-15 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US9999720B2 (en) 2012-09-27 2018-06-19 Palo Alto Research Center Incorporated Drug reconstitution and delivery device and methods
US9005108B2 (en) 2012-09-27 2015-04-14 Palo Alto Research Center Incorporated Multiple reservoir drug delivery device and methods
US9744341B2 (en) 2013-01-15 2017-08-29 Palo Alto Research Center Incorporated Devices and methods for intraluminal retention and drug delivery
WO2015038681A2 (en) * 2013-09-11 2015-03-19 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US9297083B2 (en) 2013-12-16 2016-03-29 Palo Alto Research Center Incorporated Electrolytic gas generating devices, actuators, and methods
US9801660B2 (en) 2014-07-31 2017-10-31 Palo Alto Research Center Incorporated Implantable fluid delivery devices, systems, and methods
US10278675B2 (en) 2014-07-31 2019-05-07 Palo Alto Research Center Incorporated Implantable estrus detection devices, systems, and methods
GB2535427A (en) 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
US20180021563A1 (en) * 2015-03-09 2018-01-25 Koninklijke Philips N.V. Iontophoretic device, arrangement and method
US9974858B2 (en) 2015-08-29 2018-05-22 Medrx Co., Ltd Percutaneous absorption composition
WO2017037813A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 塩基性薬物とソルビン酸とを含有する経皮吸収組成物
GB2542838B (en) 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
US11571567B2 (en) * 2016-01-05 2023-02-07 Biosensor Laboratories Inc. Iontophoresis device for drug delivery and method for manufacturing the same
CN118453496A (zh) * 2024-05-16 2024-08-09 科斯迈(武汉)生物科技有限责任公司 一种可溶性微针贴片及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3877468A (en) * 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
GB8615676D0 (en) * 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US4943435A (en) * 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
US5230896A (en) * 1989-10-12 1993-07-27 Warner-Lambert Company Transdermal nicotine delivery system
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
US5167242A (en) * 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
WO1993009842A1 (en) * 1991-11-13 1993-05-27 Elan Corporation, Plc Drug delivery device
US5756117A (en) * 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US5415629A (en) * 1993-09-15 1995-05-16 Henley; Julian L. Programmable apparatus for the transdermal delivery of drugs and method
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
JPH10511008A (ja) * 1994-06-24 1998-10-27 シグナス， インコーポレイテッド 膜透過性制御のための電子電圧パルスを用いた生物学的活性因子のパルス使用送達システム
BR9609594A (pt) * 1995-06-30 1999-02-23 Commw Scient Ind Res Org Tratamento melhorado da superfície de polímeros
US5810081A (en) * 1997-02-24 1998-09-22 Cobb; Delwin E. Wear structure for bore hole separation device
US6447143B2 (en) * 1999-12-20 2002-09-10 Mark Howard Krietzman Flat credit card illuminator with flexible integral switching arm
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
US20050118245A1 (en) * 2002-03-27 2005-06-02 Wilsmann Klaus M. Assembled unit consisting of individually separable, transdermal, therapeutic systems
EP3473251B1 (en) * 2002-12-20 2023-12-13 NicoNovum AB A nicotine-cellulose combination

Also Published As

Publication number Publication date
AU2005224182A1 (en) 2005-09-29
EP1729746B1 (en) 2009-11-18
CA2559640C (en) 2010-11-30
ES2334681T3 (es) 2010-03-15
NZ549939A (en) 2009-12-24
BRPI0508894A (pt) 2007-09-11
US20090130189A1 (en) 2009-05-21
RU2006133118A (ru) 2008-04-27
ATE448777T1 (de) 2009-12-15
WO2005089728A2 (en) 2005-09-29
IL177483A0 (en) 2006-12-10
RU2334507C2 (ru) 2008-09-27
EP1729746A2 (en) 2006-12-13
AU2005224182B2 (en) 2008-04-17
CA2559640A1 (en) 2005-09-29
DE602005017753D1 (de) 2009-12-31
DK1729746T3 (da) 2010-03-08
WO2005089728A3 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
IL177483A0 (en) Means for transdermal administration of nicotine
EP2079500A4 (en) DEVICES AND METHODS FOR INFUSION
MX2009009429A (es) Analogos de ciclopamina lactama y metodos de uso de los mismos.
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
MX2009007337A (es) Indazoles sustituidos con 5-piridinona.
NO20073065L (no) Injiserbare nanopartikulaere olanzapinformuleringer
MX2009009428A (es) Analogos de ciclopamina heterociclicos y metodos de uso de los mismos.
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
TW200740815A (en) P38 MAP kinase inhibitors and methods for using the same
TW200626068A (en) Active compounds for seed treatment
IL169881A0 (en) Adhesive patches for the transdermal delivery of granisetron
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
MX2007015424A (es) Formulaciones ungueales topicas.
NL1030220A1 (nl) Beveiliging van cryptografische communicatiesessies.
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
TW200715634A (en) Stable organic devices
MX2010004487A (es) Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular.
ATE483716T1 (de) Lösungsmittelfreies amorphes rapamycin
SG138610A1 (en) Inhaler using pods
WO2004098522A3 (en) Gemini vitamin d3 compounds and methods of use thereof
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
NO20092496L (no) Ny terapeutisk anvendelse for behandling av leukemi
PT1713438E (pt) Sabonete medicinal
TW200738244A (en) 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof
MX2007004461A (es) Composiciones farmaceuticas a base de antagonistas de nk2 para uso pediatrico.